Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Liver Diseases

  Free Subscription


Articles published in Am J Gastroenterol

Retrieve available abstracts of 164 articles:
HTML format



Single Articles


    November 2021
  1. KEHAR M, Griffiths R, Flemming JA
    Increasing Incidence of Cirrhosis Over the Past 2 Decades Among Children in Ontario, Canada.
    Am J Gastroenterol. 2021 Nov 18. pii: 00000434-990000000-00150.
    PubMed     Abstract available


  2. DUONG NK, Shrestha S, Park D, Shahab O, et al
    Bristol Stool Scale as a Determinant of Hepatic Encephalopathy Management in Patients With Cirrhosis.
    Am J Gastroenterol. 2021 Nov 5. pii: 00000434-990000000-00135.
    PubMed     Abstract available


  3. YANG D, Zhuang B, Xie X
    Hepatic Angiofibroma of Soft tissue: A Case Report.
    Am J Gastroenterol. 2021 Nov 4. pii: 00000434-990000000-00140.
    PubMed    


  4. KIM Y, Chang Y, Kwon MJ, Hong YS, et al
    Fasting Ketonuria and the Risk of Incident Nonalcoholic Fatty Liver Disease With and Without Liver Fibrosis in Nondiabetic Adults.
    Am J Gastroenterol. 2021;116:2270-2278.
    PubMed     Abstract available


    October 2021
  5. WEBER S, Gerbes AL
    Ashwagandha-Induced Liver Injury: Self-Reports on Commercial Websites as Useful Adjunct Tools for Causality Assessment.
    Am J Gastroenterol. 2021;116:2151-2152.
    PubMed    


  6. GAO X, Gao Y, Ye X, Kang W, et al
    Rare Multiple Liver Lesions With Concentric Circle Pattern.
    Am J Gastroenterol. 2021;116:1979.
    PubMed    


  7. LIN FP, Visina JM, Bloomer PM, Dunn MA, et al
    Prehabilitation-Driven Changes in Frailty Metrics Predict Mortality in Patients With Advanced Liver Disease.
    Am J Gastroenterol. 2021;116:2105-2117.
    PubMed     Abstract available


  8. BOIKE JR, Mazumder NR, Kolli KP, Ge J, et al
    Outcomes After TIPS for Ascites and Variceal Bleeding in a Contemporary Era-An ALTA Group Study.
    Am J Gastroenterol. 2021;116:2079-2088.
    PubMed     Abstract available


  9. JOHNSON DA
    "Sickeningly Sweet".... High-Fructose Corn Syrup-Caveat Emptor!
    Am J Gastroenterol. 2021;116:1970-1971.
    PubMed    


    September 2021
  10. TRIPATHI PR, Sen Sarma M, Yachha SK, Aggarwal A, et al
    Relative Adrenal Insufficiency in Decompensated Cirrhotic Children: Does It Affect Outcome?
    Am J Gastroenterol. 2021 Sep 10. pii: 00000434-990000000-00094.
    PubMed     Abstract available


  11. LEE HW, Park SY, Lee YR, Lee H, et al
    Episodic Detectable Viremia Does Not Affect Prognosis in Untreated Compensated Cirrhosis With Serum Hepatitis B Virus DNA <2,000 IU/mL.
    Am J Gastroenterol. 2021 Sep 10. pii: 00000434-990000000-00096.
    PubMed     Abstract available


  12. CHINA L, Freemantle N, Forrest E, Kallis Y, et al
    Targeted Albumin Therapy Does Not Improve Short-Term Outcome in Hyponatremic Patients Hospitalized With Complications of Cirrhosis: Data From the ATTIRE Trial.
    Am J Gastroenterol. 2021 Sep 9. pii: 00000434-990000000-00104.
    PubMed     Abstract available


  13. SHAH BJ, Onken JE, Edgar L, Jou JH, et al
    Development of gastroenterology and transplant hepatology milestones 2.0: a guide for programs, faculty, and fellows.
    Am J Gastroenterol. 2021 Sep 7. pii: 00000434-990000000-00088.
    PubMed    


  14. BLOOM PP, Robin J, Xu M, Arvind A, et al
    Hepatic Encephalopathy is Associated With Slow Speech on Objective Assessment.
    Am J Gastroenterol. 2021;116:1950-1953.
    PubMed     Abstract available


  15. CASTELLANA M, Donghia R, Guerra V, Procino F, et al
    Fibrosis-4 Index vs Nonalcoholic Fatty Liver Disease Fibrosis Score in Identifying Advanced Fibrosis in Subjects With Nonalcoholic Fatty Liver Disease: A Meta-Analysis.
    Am J Gastroenterol. 2021;116:1833-1841.
    PubMed     Abstract available


  16. THULUVATH PJ, Alukal JJ, Zhang T
    A Scoring Model to Predict In-Hospital Mortality in Patients With Budd-Chiari Syndrome.
    Am J Gastroenterol. 2021;116:1905-1912.
    PubMed     Abstract available


    August 2021
  17. SACK JS, Liu AF, Gray M, Roat J, et al
    Association of Terry Nails With Liver Cirrhosis.
    Am J Gastroenterol. 2021 Aug 27. pii: 00000434-990000000-00085.
    PubMed     Abstract available


  18. FU XL, Chen HL
    COVID-19 Vaccine for Chronic Gastroenterology and Hepatology Patients: A Need for Better Evidence.
    Am J Gastroenterol. 2021 Aug 17. pii: 00000434-990000000-00073.
    PubMed    


  19. RODRIGUEZ M, Gonzalez-Dieguez ML, Varela M, Cadahia V, et al
    Impact of Alcohol Abstinence on the Risk of Hepatocellular Carcinoma in Patients With Alcohol-Related Liver Cirrhosis.
    Am J Gastroenterol. 2021 Aug 16. pii: 00000434-990000000-00111.
    PubMed     Abstract available


  20. SCHNEIDER CV, Fromme M, Schneider KM, Bruns T, et al
    Mortality in Patients With Genetic and Environmental Risk of Liver Disease.
    Am J Gastroenterol. 2021;116:1741-1745.
    PubMed     Abstract available


  21. TAGUCHI YV, Snyder DL, Shah JB, Dickson RC, et al
    Deglutition Syncope After Variceal Band Ligation.
    Am J Gastroenterol. 2021;116:1763.
    PubMed    


  22. HASHEMIAN M, Merat S, Poustchi H, Jafari E, et al
    Red Meat Consumption and Risk of Nonalcoholic Fatty Liver Disease in a Population With Low Meat Consumption: The Golestan Cohort Study.
    Am J Gastroenterol. 2021;116:1667-1675.
    PubMed     Abstract available


    July 2021
  23. MOCTEZUMA-VELAZQUEZ C, Abraldes JG
    Statins and Liver Cancer in Cirrhosis: The Most Relevant Questions Are Still Unanswered.
    Am J Gastroenterol. 2021 Jul 19. pii: 00000434-990000000-00051.
    PubMed     Abstract available


  24. LABENZ C, Labenz J
    Proton Pump Inhibitors in Patients With Liver Cirrhosis: Evidence to Improve Their Battered Reputation.
    Am J Gastroenterol. 2021 Jul 19. pii: 00000434-990000000-00048.
    PubMed    


  25. USHIDA K, Shimizu M, Yamamoto Y, Momosaki R, et al
    Strategies to Improve Exercise Adherence in Patients With Cirrhosis.
    Am J Gastroenterol. 2021 Jul 13. pii: 00000434-990000000-00043.
    PubMed    


  26. PINYOPORNPANISH K, Al-Yaman W, Butler RS, Carey W, et al
    Chemopreventive Effect of Statin on Hepatocellular Carcinoma in Patients With Nonalcoholic Steatohepatitis Cirrhosis.
    Am J Gastroenterol. 2021 Jul 2. pii: 00000434-990000000-00036.
    PubMed     Abstract available


  27. MATTOS AZ, Leao GS, Bombassaro IZ, Chiesa T, et al
    Definitions for Acute-on-Chronic Liver Failure: In Dubio Pro Reo.
    Am J Gastroenterol. 2021;116:1550.
    PubMed    


  28. VAN J, Aloman C, Reau N
    Potential Bias and Misconceptions in Liver Transplantation for Alcohol- and Obesity-Related Liver Disease.
    Am J Gastroenterol. 2021 Jul 1. pii: 00000434-990000000-00032.
    PubMed     Abstract available


    June 2021
  29. JINDAL A, Mukund A
    Management of Portal Vein Thrombosis in Cirrhosis-Need a Closer Look!
    Am J Gastroenterol. 2021 Jun 30. pii: 00000434-990000000-00025.
    PubMed    


  30. ZHAI LL, Tang ZG
    Effect of Vitamin D Supplementation on Vitamin D Level and Bone Mineral Density in Patients With Cirrhosis: Several Confounding Factors.
    Am J Gastroenterol. 2021 Jun 23. pii: 00000434-990000000-00016.
    PubMed    


  31. REIG A, Alvarez-Navascues C, Vergara M, Gomez-Dominguez E, et al
    Obeticholic Acid and Fibrates in Primary Biliary Cholangitis: Comparative Effects in a Multicentric Observational Study.
    Am J Gastroenterol. 2021 Jun 23. pii: 00000434-990000000-00017.
    PubMed     Abstract available


  32. ACHARYA C, Nadhem O, Shaw J, Hassouneh R, et al
    Liver-Unrelated Comorbid Conditions Do Not Affect Cognitive Performance or Hepatic Encephalopathy Progression in Cirrhosis.
    Am J Gastroenterol. 2021 Jun 18. pii: 00000434-990000000-00012.
    PubMed     Abstract available


  33. LOUISSAINT J, May FP, Williams S, Tapper EB, et al
    Effective Mentorship as a Means to Recruit, Retain, and Promote Underrepresented Minorities in Academic Gastroenterology and Hepatology.
    Am J Gastroenterol. 2021;116:1110-1113.
    PubMed    


  34. CRAVEN LJ, Parvathy SN, Burton JP, Silverman MS, et al
    Response to Ianiro et al.
    Am J Gastroenterol. 2021;116:1361-1362.
    PubMed    


  35. IANIRO G, Porcari S, Gasbarrini A, Cammarota G, et al
    Quantity of Donor Stool for Fecal Microbiota Transplantation: The More, the Better?
    Am J Gastroenterol. 2021;116:1360-1361.
    PubMed    


  36. BENMASSAOUD A, Tsochatzis E
    Response to Debnath and Rathi.
    Am J Gastroenterol. 2021;116:1358-1359.
    PubMed    


  37. DEBNATH P, Rathi P
    Sarcopenia and TIPS: How Best to Measure Muscle Mass.
    Am J Gastroenterol. 2021;116:1358.
    PubMed    


  38. WU F, Pahkala K, Juonala M, Jaakkola J, et al
    Childhood and Adulthood Passive Smoking and Nonalcoholic Fatty Liver in Midlife: A 31-year Cohort Study.
    Am J Gastroenterol. 2021;116:1256-1263.
    PubMed     Abstract available


    May 2021
  39. HERNANDEZ-CONDE M, Llop E, Gomez-Pimpollo L, Fernandez Carrillo C, et al
    Adding Branched-Chain Amino Acids to an Enhanced Standard-of-Care Treatment Improves Muscle Mass of Cirrhotic Patients With Sarcopenia: A Placebo-Controlled Trial.
    Am J Gastroenterol. 2021 May 26. pii: 00000434-900000000-98756.
    PubMed     Abstract available


  40. FARUQUI S, Okoli FC, Olsen SK, Feldman DM, et al
    Cholangiopathy After Severe COVID-19: Clinical Features and Prognostic Implications.
    Am J Gastroenterol. 2021 May 17. pii: 00000434-900000000-98779.
    PubMed     Abstract available


  41. JOHN BV, Khakoo NS, Schwartz KB, Aitchenson G, et al
    Ursodeoxycholic Acid Response Is Associated With Reduced Mortality in Primary Biliary Cholangitis With Compensated Cirrhosis.
    Am J Gastroenterol. 2021 May 13. pii: 00000434-900000000-98782.
    PubMed     Abstract available


  42. GOET JC, Murillo Perez CF, Harms MH, Floreani A, et al
    A Comparison of Prognostic Scores (Mayo, UK-PBC, and GLOBE) in Primary Biliary Cholangitis.
    Am J Gastroenterol. 2021 May 4. pii: 00000434-900000000-98792.
    PubMed     Abstract available


  43. WANG R, Yang L, Hu C, Yan J, et al
    A Tip of the Iceberg on the Mechanism of SARS-CoV-2-Induced Liver Injury.
    Am J Gastroenterol. 2021;116:1097-1098.
    PubMed    


  44. BENMASSAOUD A, Tsochatzis E
    Response to Anand and Sharma.
    Am J Gastroenterol. 2021;116:1094-1095.
    PubMed    


  45. BJORNSSON HK, Bjornsson ES
    Database Studies on Drug-Induced Liver Injury: The Importance of Causality Assessment.
    Am J Gastroenterol. 2021;116:1090-1091.
    PubMed    


  46. CHALASANI NP, Maddur H, Russo MW, Wong RJ, et al
    ACG Clinical Guideline: Diagnosis and Management of Idiosyncratic Drug-Induced Liver Injury.
    Am J Gastroenterol. 2021;116:878-898.
    PubMed     Abstract available


  47. VILAR-GOMEZ E, Pirola CJ, Sookoian S, Wilson LA, et al
    Impact of the Association Between PNPLA3 Genetic Variation and Dietary Intake on the Risk of Significant Fibrosis in Patients With NAFLD.
    Am J Gastroenterol. 2021;116:994-1006.
    PubMed     Abstract available


  48. YATACO ML, Bowman AW, Keaveny AP
    Management of the Incidental Liver Lesion.
    Am J Gastroenterol. 2021;116:855-861.
    PubMed    


  49. ESLAM M, Wong GL, Hashem AM, Chan HL, et al
    A Sequential Algorithm Combining ADAPT and Liver Stiffness Can Stage Metabolic-Associated Fatty Liver Disease in Hospital-Based and Primary Care Patients.
    Am J Gastroenterol. 2021;116:984-993.
    PubMed     Abstract available


    April 2021
  50. GROVER I, Gunjan D, Singh N, Benjamin J, et al
    Effect of Vitamin D Supplementation on Vitamin D Level and Bone Mineral Density in Patients With Cirrhosis: A Randomized Clinical Trial.
    Am J Gastroenterol. 2021 Apr 29. pii: 00000434-900000000-98797.
    PubMed     Abstract available


  51. TRAN S, Jeong D, Henry L, Cheung RC, et al
    Initial Evaluation, Long-Term Monitoring, and Hepatocellular Carcinoma Surveillance of Chronic Hepatitis B in Routine Practice: A Nationwide US Study.
    Am J Gastroenterol. 2021 Apr 29. pii: 00000434-900000000-98796.
    PubMed     Abstract available


  52. THORNTON C, Somayaji R, Parkins M, Swain MG, et al
    Characteristics and Outcomes of Children With Cystic Fibrosis Hospitalized With Cirrhosis in the United States.
    Am J Gastroenterol. 2021 Apr 29. pii: 00000434-900000000-98795.
    PubMed     Abstract available


  53. MA C, Qian AS, Nguyen NH, Stukalin I, et al
    Trends in the Economic Burden of Chronic Liver Diseases and Cirrhosis in the United States: 1996-2016.
    Am J Gastroenterol. 2021 Apr 28. doi: 10.14309/ajg.0000000000001292.
    PubMed     Abstract available


  54. KAWAGUCHI Y, Hasegawa K, Hagiwara Y, De Bellis M, et al
    Effect of Diameter and Number of Hepatocellular Carcinomas on Survival After Resection, Transarterial Chemoembolization, and Ablation.
    Am J Gastroenterol. 2021 Apr 21. pii: 00000434-900000000-98811.
    PubMed     Abstract available


  55. SERPER M, Reddy KR, Bewtra M, Ahmad N, et al
    COVID-19 Vaccine Perceptions Among Patients With Chronic Disease in a Large Gastroenterology and Hepatology Practice.
    Am J Gastroenterol. 2021 Apr 19. pii: 00000434-900000000-98813.
    PubMed     Abstract available


  56. SHARMA S, Saraya A
    Avoiding Beta Blockers in Patients of Hepatitis C Virus-Related Compensated Cirrhosis With Clinically Significant Portal Hypertension After Cure With Antivirals: Are We There Yet?
    Am J Gastroenterol. 2021 Apr 9. pii: 00000434-900000000-98829.
    PubMed    


  57. KHALILI M, Kleiner DE, King WC, Sterling RK, et al
    Hepatic Steatosis and Steatohepatitis in a Large North American Cohort of Adults With Chronic Hepatitis B.
    Am J Gastroenterol. 2021 Apr 8. pii: 00000434-900000000-98823.
    PubMed     Abstract available


  58. SONI D, Roy A, De A, Verma N, et al
    MASQ-HE: Unmasking the Predictors of Overt Hepatic Encephalopathy?
    Am J Gastroenterol. 2021;116:836-837.
    PubMed    


  59. MORTON A
    Measuring Serum Sodium in Cirrhosis: Regarding "Hyponatremia in Cirrhosis: An Update".
    Am J Gastroenterol. 2021;116:835.
    PubMed    


  60. PONS M, Augustin S, Scheiner B, Guillaume M, et al
    Noninvasive Diagnosis of Portal Hypertension in Patients With Compensated Advanced Chronic Liver Disease.
    Am J Gastroenterol. 2021;116:723-732.
    PubMed     Abstract available


  61. LAI JC, Dodge JL, Kappus MR, Wong R, et al
    A Multicenter Pilot Randomized Clinical Trial of a Home-Based Exercise Program for Patients With Cirrhosis: The Strength Training Intervention (STRIVE).
    Am J Gastroenterol. 2021;116:717-722.
    PubMed     Abstract available


  62. KOTANI K, Uchida-Kobayashi S, Yoshida K, Kawamura E, et al
    Lenvatinib-Induced Tumor-Related Hemorrhage in Patients With Unresectable Hepatocellular Carcinoma.
    Am J Gastroenterol. 2021;116:631.
    PubMed    


  63. TAPPER EB
    Finding Common Ground With Our MASQs Off.
    Am J Gastroenterol. 2021;116:837.
    PubMed    


  64. ALUKAL JJ, Thuluvath PJ
    Reply to Morton.
    Am J Gastroenterol. 2021;116:835-836.
    PubMed    


  65. YAMADA G, Hagiwara Y, Kimura T, Takeuchi Y, et al
    Impact of Body Weight Gain on the Incidence of Nonalcoholic Fatty Liver Disease in Nonobese Japanese Individuals.
    Am J Gastroenterol. 2021;116:733-740.
    PubMed     Abstract available


  66. KOK B, McNeely M, Watt M, Tandon P, et al
    Exercise Only Works If You Do It! The Holy Grail of Adherence.
    Am J Gastroenterol. 2021;116:673-674.
    PubMed     Abstract available


    March 2021
  67. ROGAL S, Youk A, Agbalajobi O, Zhang H, et al
    Medication Treatment of Active Opioid Use Disorder in Veterans With Cirrhosis.
    Am J Gastroenterol. 2021 Mar 30. pii: 00000434-900000000-98834.
    PubMed     Abstract available


  68. AYOUB F, Ouni A, Case R, Ladna M, et al
    Dissemination of Gastroenterology and Hepatology Research on Social Media Platforms Is Associated With Increased Citation Count.
    Am J Gastroenterol. 2021 Mar 22. pii: 00000434-900000000-98848.
    PubMed     Abstract available


  69. JANSSON-KNODELL CL, Calderon G, Weber R, Ghabril M, et al
    Small Intestine Varices in Cirrhosis at a High-Volume Liver Transplant Center: A Retrospective Database Study and Literature Review.
    Am J Gastroenterol. 2021 Mar 10. pii: 00000434-900000000-98858.
    PubMed     Abstract available


  70. CHANDEL S, Singh V
    Hyponatremia in Cirrhosis: Role of Vasopressors.
    Am J Gastroenterol. 2021 Mar 10. pii: 00000434-900000000-98857.
    PubMed    


  71. NAM H, Lee SW, Kwon JH, Lee HL, et al
    Prediction of Hepatocellular Carcinoma by On-Therapy Response of Noninvasive Fibrosis Markers in Chronic Hepatitis B.
    Am J Gastroenterol. 2021 Mar 10. pii: 00000434-900000000-98856.
    PubMed     Abstract available


  72. GIL-GOMEZ A, Ampuero J, Rojas A, Gallego-Duran R, et al
    Development and Validation of a Clinical-Genetic Risk Score to Predict Hepatic Encephalopathy in Patients With Liver Cirrhosis.
    Am J Gastroenterol. 2021 Mar 2. pii: 00000434-900000000-98817.
    PubMed     Abstract available


  73. WONG RJ, Jain MK, Therapondos G, Niu B, et al
    Antiviral Therapy Reduces Risk of Cirrhosis in Noncirrhotic HBV Patients Among 4 Urban Safety-Net Health Systems.
    Am J Gastroenterol. 2021 Mar 1. pii: 00000434-900000000-98873.
    PubMed     Abstract available


  74. BRAILLON A
    Hepatocellular Carcinoma in Women: Could Tobacco Matter More than Sex?
    Am J Gastroenterol. 2021;116:617.
    PubMed    


  75. SUBRAMANIAM M, Azad N, Wasan SK, Long MT, et al
    Equal Opportunity: Women Representation on Editorial Boards and Authorship of Editorials in Gastroenterology and Hepatology Journals.
    Am J Gastroenterol. 2021;116:613-616.
    PubMed     Abstract available


  76. MONROSE E, Bui A, Rosenbluth E, Dickstein D, et al
    Burden of Future Liver Abnormalities in Patients With Intrahepatic Cholestasis of Pregnancy.
    Am J Gastroenterol. 2021;116:568-575.
    PubMed     Abstract available


  77. SHAUKAT A, Oxentenko AS
    The Time Is Now to Understand and Address Sex-Related Disparities in Gastroenterology and Hepatology.
    Am J Gastroenterol. 2021;116:441-443.
    PubMed     Abstract available


  78. PHIPPS M, Wattacheril J
    Response to Braillon.
    Am J Gastroenterol. 2021;116:617-618.
    PubMed    


  79. VALENTIN N, Guerrido I, Rozenshteyn F, Pinotti R, et al
    Pregnancy Outcomes After Liver Transplantation: A Systematic Review and Meta-Analysis.
    Am J Gastroenterol. 2021;116:491-504.
    PubMed     Abstract available


    February 2021
  80. BAJAJ JS
    The Three Villages of Hepatic Encephalopathy.
    Am J Gastroenterol. 2021 Feb 26. pii: 00000434-900000000-98870.
    PubMed     Abstract available


  81. LV Y, Bai W, Li K, Wang Z, et al
    Anticoagulation and Transjugular Intrahepatic Portosystemic Shunt for the Management of Portal Vein Thrombosis in Cirrhosis: A Prospective Observational Study.
    Am J Gastroenterol. 2021 Feb 25. pii: 00000434-900000000-98874.
    PubMed     Abstract available


  82. TOSETTI G, Degasperi E, Farina E, D'Ambrosio R, et al
    Decompensation in Direct-Acting Antiviral Cured Hepatitis C Virus Compensated Patients With Clinically Significant Portal Hypertension: Too Rare to Warrant Universal Beta-Blocker Therapy.
    Am J Gastroenterol. 2021 Feb 18. pii: 00000434-900000000-98881.
    PubMed     Abstract available


  83. TAN HK, Teng MLP, Soh AYS, Cheo SHY, et al
    Poor Outcomes of Cirrhosis due to Nonalcoholic Steatohepatitis Compared With Hepatitis B After Decompensation With Ascites.
    Am J Gastroenterol. 2021 Feb 1. doi: 10.14309/ajg.0000000000001176.
    PubMed     Abstract available


    January 2021
  84. SAWAS T, Dilmaghani S, Dhaliwal L, Wang KK, et al
    Risk Factor Profiles Can Distinguish Esophageal Adenocarcinoma From Barrett's Esophagus.
    Am J Gastroenterol. 2021;116:198-201.
    PubMed     Abstract available


  85. LEE JI, Lee HW, Lee KS, Lee HS, et al
    Effects of Statin Use on the Development and Progression of Nonalcoholic Fatty Liver Disease: A Nationwide Nested Case-Control Study.
    Am J Gastroenterol. 2021;116:116-124.
    PubMed     Abstract available


    December 2020
  86. LAI JC, Dodge JL, Kappus MR, Wong R, et al
    A Multicenter Pilot Randomized Clinical Trial of a Home-Based Exercise Program for Patients With Cirrhosis: The Strength Training Intervention (STRIVE).
    Am J Gastroenterol. 2020;Publish Ahead of Print.
    PubMed     Abstract available


  87. YOUNOSSI ZM, Noureddin M, Bernstein D, Kwo P, et al
    Role of Noninvasive Tests in Clinical Gastroenterology Practices to Identify Patients With Nonalcoholic Steatohepatitis at High Risk of Adverse Outcomes: Expert Panel Recommendations.
    Am J Gastroenterol. 2020 Dec 7. doi: 10.14309/ajg.0000000000001054.
    PubMed     Abstract available


    November 2020
  88. KIM NJ, Jacob DA, Ioannou GN, John BV, et al
    Rates and Predictors of Undergoing Different Hepatocellular Carcinoma Screening Tests in Patients With Cirrhosis.
    Am J Gastroenterol. 2020 Nov 26. doi: 10.14309/ajg.0000000000001000.
    PubMed     Abstract available


  89. SHARMA S, Agarwal S, Anand A
    Noninvasive Diagnosis of Clinically Significant Portal Hypertension in Patients With Compensated Liver Disease: Whom and How to Screen?
    Am J Gastroenterol. 2020 Nov 23. doi: 10.14309/ajg.0000000000001078.
    PubMed    


  90. ANAND A, Sharma S
    Sarcopenia Does Not Worsen Outcomes in Patients With Refractory Ascites Under Transjugular Intrahepatic Portosystemic Shunt Placement-Preliminary Evidence?
    Am J Gastroenterol. 2020 Nov 10. doi: 10.14309/ajg.0000000000001053.
    PubMed    


  91. BENMASSAOUD A, Roccarina D, Arico F, Leandro G, et al
    Sarcopenia Does Not Worsen Survival in Patients With Cirrhosis Undergoing Transjugular Intrahepatic Portosystemic Shunt for Refractory Ascites.
    Am J Gastroenterol. 2020;115:1911-1914.
    PubMed     Abstract available


  92. CHEDID VG, Kamath AA, M Knudsen J, Frimannsdottir K, et al
    Three-Dimensional-Printed Liver Model Helps Learners Identify Hepatic Subsegments: A Randomized-Controlled Cross-Over Trial.
    Am J Gastroenterol. 2020;115:1906-1910.
    PubMed     Abstract available


  93. ARE VS, Knapp SM, Banerjee A, Shamseddeen H, et al
    Improving Outcomes of Bariatric Surgery in Patients With Cirrhosis in the United States: A Nationwide Assessment.
    Am J Gastroenterol. 2020;115:1849-1856.
    PubMed     Abstract available


  94. ALUKAL JJ, John S, Thuluvath PJ
    Hyponatremia in Cirrhosis: An Update.
    Am J Gastroenterol. 2020;115:1775-1785.
    PubMed     Abstract available


  95. AHMED O, Pillai A
    Hepatocellular Carcinoma: A Contemporary Approach to Locoregional Therapy.
    Am J Gastroenterol. 2020;115:1733-1736.
    PubMed    


    October 2020
  96. LIU W, Wang S, Guo J, Liu X, et al
    A Bolt Method of Treating the Stent Migration After Endoscopic Ultrasound-Guided Hepaticogastrostomy.
    Am J Gastroenterol. 2020 Oct 28. doi: 10.14309/ajg.0000000000000938.
    PubMed    


  97. LEE BP, Dodge JL, Terrault NA
    Excess Mortality After Liver Transplantation in Young Women With Alcohol-Associated Liver Disease.
    Am J Gastroenterol. 2020 Oct 28. doi: 10.14309/ajg.0000000000001007.
    PubMed     Abstract available


  98. THULUVATH PJ, To C, Amjad W
    Role of Locoregional Therapies in Patients With Hepatocellular Cancer Awaiting Liver Transplantation.
    Am J Gastroenterol. 2020 Oct 23. doi: 10.14309/ajg.0000000000000999.
    PubMed     Abstract available


  99. MORTON A
    Measuring Serum Sodium in Cirrhosis: Regarding "Hyponatremia in Cirrhosis: An Update".
    Am J Gastroenterol. 2020 Oct 19. doi: 10.14309/ajg.0000000000001011.
    PubMed    


  100. SONI D, Roy A, De A, Verma N, et al
    MASQ-HE: Unmasking the Predictors of Overt Hepatic Encephalopathy?
    Am J Gastroenterol. 2020 Oct 19. doi: 10.14309/ajg.0000000000001010.
    PubMed    


  101. ARE VS, Knapp SM, Banerjee A, Shamseddeen H, et al
    Improving Outcomes of Bariatric Surgery in Patients With Cirrhosis in the United States: A Nationwide Assessment.
    Am J Gastroenterol. 2020 Oct 19. doi: 10.14309/ajg.0000000000000911.
    PubMed     Abstract available


  102. KIM JH, Kim DJ, Kwon CI
    Pseudoaneurysmal Rupture of the Hepatic Artery Caused by a Biliary Plastic Stent.
    Am J Gastroenterol. 2020 Oct 15. doi: 10.14309/ajg.0000000000000982.
    PubMed    


  103. REIG A, Norman GL, Pares A
    Surrogate Markers for Antimitochondrial Antibody Negative Primary Biliary Cholangitis.
    Am J Gastroenterol. 2020 Oct 15. doi: 10.14309/ajg.0000000000000980.
    PubMed    


  104. OZDOGAN E, Doganay L, Can D, Arikan C, et al
    Disease Course and Treatment Response of Eosinophilic Gastrointestinal Diseases in Children With Liver Transplantation: Long-Term Follow-Up.
    Am J Gastroenterol. 2020 Oct 13. doi: 10.14309/ajg.0000000000000934.
    PubMed     Abstract available


  105. BENMASSAOUD A, Roccarina D, Arico F, Leandro G, et al
    Sarcopenia Does Not Worsen Survival in Patients With Cirrhosis Undergoing Transjugular Intrahepatic Portosystemic Shunt for Refractory Ascites.
    Am J Gastroenterol. 2020 Oct 12. doi: 10.14309/ajg.0000000000000959.
    PubMed     Abstract available


  106. HU C, Anjur V, Saboo K, Reddy KR, et al
    Low Predictability of Readmissions and Death Using Machine Learning in Cirrhosis.
    Am J Gastroenterol. 2020 Oct 8. doi: 10.14309/ajg.0000000000000971.
    PubMed     Abstract available


  107. PILLAI A, Ahn J, Kulik L
    Integrating Genomics Into Clinical Practice in Hepatocellular Carcinoma: The Challenges Ahead.
    Am J Gastroenterol. 2020 Oct 8. doi: 10.14309/ajg.0000000000000843.
    PubMed     Abstract available


  108. PONS M, Augustin S, Scheiner B, Guillaume M, et al
    Noninvasive Diagnosis of Portal Hypertension in Patients With Compensated Advanced Chronic Liver Disease.
    Am J Gastroenterol. 2020 Oct 8. doi: 10.14309/ajg.0000000000000994.
    PubMed     Abstract available


  109. KALAMBOKIS GN, Tsiakas I, Filippas-Ntekuan S, Christaki M, et al
    Empagliflozin Eliminates Refractory Ascites and Hepatic Hydrothorax in a Patient With Primary Biliary Cirrhosis.
    Am J Gastroenterol. 2020 Oct 7. doi: 10.14309/ajg.0000000000000995.
    PubMed    


  110. CHEN PT, Tzeng HL, Wang HP, Liu KL, et al
    Caput Medusae Bleeding.
    Am J Gastroenterol. 2020;115:1570.
    PubMed    


    September 2020
  111. AHMED O, Pillai A
    Hepatocellular Carcinoma: A Contemporary Approach to Locoregional Therapy.
    Am J Gastroenterol. 2020 Sep 30. doi: 10.14309/ajg.0000000000000931.
    PubMed    


  112. GRANITO A, Muratori L, Tovoli F, Muratori P, et al
    Surrogate Markers for Antimitochondrial Antibody-Negative Primary Biliary Cholangitis.
    Am J Gastroenterol. 2020 Sep 28. doi: 10.14309/ajg.0000000000000928.
    PubMed    


  113. WONG RJ, Saab S, Konyn P, Sundaram V, et al
    Rural-Urban Geographical Disparities in Hepatocellular Carcinoma Incidence Among US Adults, 2004-2017.
    Am J Gastroenterol. 2020 Sep 24. doi: 10.14309/ajg.0000000000000948.
    PubMed     Abstract available


  114. CHEDID VG, Kamath AA, M Knudsen J, Frimannsdottir K, et al
    Three-Dimensional-Printed Liver Model Helps Learners Identify Hepatic Subsegments: A Randomized-Controlled Cross-Over Trial.
    Am J Gastroenterol. 2020 Sep 24. doi: 10.14309/ajg.0000000000000958.
    PubMed     Abstract available


  115. CARBALLO-FOLGOSO L, Alvarez-Navascues C, Rodriguez M
    Acute Liver Failure Associated With Ulipristal Acetate: A Case Report.
    Am J Gastroenterol. 2020;115:1542-1544.
    PubMed    


  116. KIM D, Vazquez-Montesino LM, Escober JA, Fernandes CT, et al
    Low Thyroid Function in Nonalcoholic Fatty Liver Disease Is an Independent Predictor of All-Cause and Cardiovascular Mortality.
    Am J Gastroenterol. 2020;115:1496-1504.
    PubMed     Abstract available


  117. ZHAO J, Blais JE, Chui CSL, Suh IH, et al
    Association Between Nonvitamin K Antagonist Oral Anticoagulants or Warfarin and Liver Injury: A Cohort Study.
    Am J Gastroenterol. 2020;115:1513-1524.
    PubMed     Abstract available


    August 2020
  118. WHITFIELD JB, Masson S, Liangpunsakul S, Mueller S, et al
    Obesity, Diabetes, Coffee, Tea, and Cannabis Use Alter Risk for Alcohol-Related Cirrhosis in 2 Large Cohorts of High-Risk Drinkers.
    Am J Gastroenterol. 2020 Aug 31. doi: 10.14309/ajg.0000000000000833.
    PubMed     Abstract available


  119. CAO Z, Liu Y, Cai M, Xu Y, et al
    The Use of NACSELD and EASL-CLIF Classification Systems of ACLF in the Prediction of Prognosis in Hospitalized Patients With Cirrhosis.
    Am J Gastroenterol. 2020 Aug 27. doi: 10.14309/ajg.0000000000000771.
    PubMed     Abstract available


  120. YE L, Zhang C, Seidensticker M, Mayerle J, et al
    Durable Complete Response of Brain Metastasis From Hepatocellular Carcinoma On Treatment With Nivolumab and Radiation Treatment.
    Am J Gastroenterol. 2020 Aug 26. doi: 10.14309/ajg.0000000000000800.
    PubMed    


  121. LOPEZ-TOBARUELA JM, Valverde-Lopez F, Lopez de Hierro-Ruiz M, Redondo-Cerezo E, et al
    Hepatic Abscess After Biodegradable Esophageal Stent Placement: A Rare Complication.
    Am J Gastroenterol. 2020 Aug 19. doi: 10.14309/ajg.0000000000000821.
    PubMed    


  122. TAPPER EB, Zhao L, Nikirk S, Baki J, et al
    Incidence and Bedside Predictors of the First Episode of Overt Hepatic Encephalopathy in Patients With Cirrhosis.
    Am J Gastroenterol. 2020 Aug 6. doi: 10.14309/ajg.0000000000000762.
    PubMed     Abstract available


  123. ALUKAL JJ, John S, Thuluvath PJ
    Hyponatremia in Cirrhosis: An Update.
    Am J Gastroenterol. 2020 Aug 6. doi: 10.14309/ajg.0000000000000786.
    PubMed     Abstract available


  124. REVERTER E, Ott P
    Compensated Cirrhosis and 20 mm Hg: A Point of No Return?
    Am J Gastroenterol. 2020 Aug 5. doi: 10.14309/ajg.0000000000000770.
    PubMed     Abstract available


  125. ZHANG X, Tang C, Tian D, Hou X, et al
    Management of Digestive Disorders and Procedures Associated With COVID-19.
    Am J Gastroenterol. 2020;115:1153-1155.
    PubMed    


  126. YOUNES R, Govaere O, Petta S, Miele L, et al
    Presence of Serum Antinuclear Antibodies Does Not Impact Long-Term Outcomes in Nonalcoholic Fatty Liver Disease.
    Am J Gastroenterol. 2020;115:1289-1292.
    PubMed     Abstract available


    July 2020
  127. SAMOYLOVA ML, Kapila N, McElroy L, Suhocki P, et al
    Gastrohepatic Fistula After Y-90 Embolization of Hepatocellular Carcinoma.
    Am J Gastroenterol. 2020 Jul 31. doi: 10.14309/ajg.0000000000000793.
    PubMed    


  128. LEVY C, Bowlus CL
    Role of Antinuclear Antibodies in Primary Biliary Cholangitis.
    Am J Gastroenterol. 2020 Jul 22. doi: 10.14309/ajg.0000000000000765.
    PubMed     Abstract available


  129. GAO F, Zheng KI, Fan YC, Targher G, et al
    ACE2: A Linkage for the Interplay Between COVID-19 and Decompensated Cirrhosis.
    Am J Gastroenterol. 2020 Jul 16. doi: 10.14309/ajg.0000000000000780.
    PubMed    


  130. KOTANI K, Uchida-Kobayashi S, Yoshida K, Kawamura E, et al
    Lenvatinib-Induced Tumor-Related Hemorrhage in Patients With Unresectable Hepatocellular Carcinoma.
    Am J Gastroenterol. 2020 Jul 14. doi: 10.14309/ajg.0000000000000747.
    PubMed    


  131. RUBIN JN, Gilman CAL, Gasmi B, Stern WR, et al
    Hepatocellular Carcinoma Where You Least Expect It.
    Am J Gastroenterol. 2020;115:1134-1136.
    PubMed    


  132. BAJAJ JS, Brenner DM, Cai Q, Cash BD, et al
    Major Trends in Gastroenterology and Hepatology Between 2010 and 2019: An Overview of Advances From the Past Decade Selected by the Editorial Board of The American Journal of Gastroenterology.
    Am J Gastroenterol. 2020;115:1007-1018.
    PubMed    


  133. BAJAJ JS, Lauridsen M, Tapper EB, Duarte-Rojo A, et al
    Important Unresolved Questions in the Management of Hepatic Encephalopathy: An ISHEN Consensus.
    Am J Gastroenterol. 2020;115:989-1002.
    PubMed     Abstract available


  134. BOWER RJ, Frenette C
    Reevaluating Goals of Therapy in Primary Biliary Cholangitis: Is Good Enough Is Not Good Enough Anymore?
    Am J Gastroenterol. 2020;115:1024-1025.
    PubMed     Abstract available


  135. CRAVEN L, Rahman A, Nair Parvathy S, Beaton M, et al
    Allogenic Fecal Microbiota Transplantation in Patients With Nonalcoholic Fatty Liver Disease Improves Abnormal Small Intestinal Permeability: A Randomized Control Trial.
    Am J Gastroenterol. 2020;115:1055-1065.
    PubMed     Abstract available


    June 2020
  136. BAJAJ JS, Brenner DM, Cai Q, Cash BD, et al
    Major Trends in Gastroenterology and Hepatology Between 2010 and 2019: An Overview of Advances From the Past Decade Selected by the Editorial Board of The American Journal of Gastroenterology.
    Am J Gastroenterol. 2020 Jun 23. doi: 10.14309/ajg.0000000000000709.
    PubMed    


  137. PARIKH ND, Singal AG, Hutton DW, Tapper EB, et al
    Cost-Effectiveness of Hepatocellular Carcinoma Surveillance: An Assessment of Benefits and Harms.
    Am J Gastroenterol. 2020 Jun 9. doi: 10.14309/ajg.0000000000000715.
    PubMed     Abstract available


  138. KOSHY AN, Farouque O, Gow PJ
    Response to Singh, et al.
    Am J Gastroenterol. 2020;115:951-952.
    PubMed    


  139. MANCUSO A, Amata M, Politi F, Mitra M, et al
    Controversies in Budd-Chiari Syndrome Management: Potential Role of Liver Stiffness.
    Am J Gastroenterol. 2020;115:952-953.
    PubMed    


  140. SAAB S, Kim NG, Lee EW
    Practical Tips on TIPS: When and When Not to Request It.
    Am J Gastroenterol. 2020;115:797-800.
    PubMed    


  141. XU L, Xie J, Chen S, Chen Y, et al
    Light-to-Moderate Alcohol Consumption Is Associated With Increased Risk of Type 2 Diabetes in Individuals With Nonalcoholic Fatty Liver Disease: A Nine-Year Cohort Study.
    Am J Gastroenterol. 2020;115:876-884.
    PubMed     Abstract available


    May 2020
  142. REIG A, Norman GL, Garcia M, Shums Z, et al
    Novel Anti-Hexokinase 1 Antibodies Are Associated With Poor Prognosis in Patients With Primary Biliary Cholangitis.
    Am J Gastroenterol. 2020 May 27. doi: 10.14309/ajg.0000000000000690.
    PubMed     Abstract available


  143. PHIPPS M, Livanos A, Guo A, Pomenti S, et al
    Gender Matters: Characteristics of Hepatocellular Carcinoma in Women From a Large, Multicenter Study in the United States.
    Am J Gastroenterol. 2020 May 22. doi: 10.14309/ajg.0000000000000643.
    PubMed     Abstract available


  144. JINDAL A, Bhardwaj A, Kumar G, Sarin SK, et al
    Clinical Decompensation and Outcomes in Patients With Compensated Cirrhosis and a Hepatic Venous Pressure Gradient >/=20 mm Hg.
    Am J Gastroenterol. 2020 May 21. doi: 10.14309/ajg.0000000000000653.
    PubMed     Abstract available


  145. PATIDAR KR, Shamseddeen H, Xu C, Ghabril MS, et al
    Hospital-Acquired Versus Community-Acquired Acute Kidney Injury in Patients With Cirrhosis: A Prospective Study.
    Am J Gastroenterol. 2020 May 5. doi: 10.14309/ajg.0000000000000670.
    PubMed     Abstract available


  146. VIJAYARAGHAVAN R, Jindal A, Arora V, Choudhary A, et al
    Hemodynamic Effects of Adding Simvastatin to Carvedilol for Primary Prophylaxis of Variceal Bleeding: A Randomized Controlled Trial.
    Am J Gastroenterol. 2020;115:729-737.
    PubMed     Abstract available


    April 2020
  147. RUBIN JN, Gilman CAL, Gasmi B, Stern WR, et al
    Hepatocellular Carcinoma Where You Least Expect It.
    Am J Gastroenterol. 2020 Apr 10. doi: 10.14309/ajg.0000000000000616.
    PubMed    


  148. MOON AM, Kim HP, Barritt AS 4th, Darling J, et al
    A Quality Improvement Initiative Results in Improved Rates of Timely Postvariceal Bleeding Surveillance Endoscopy.
    Am J Gastroenterol. 2020;115:625-628.
    PubMed     Abstract available


  149. HAN E, Lee YH, Kim YD, Kim BK, et al
    Nonalcoholic Fatty Liver Disease and Sarcopenia Are Independently Associated With Cardiovascular Risk.
    Am J Gastroenterol. 2020;115:584-595.
    PubMed     Abstract available


    March 2020
  150. SALIM TI, Nestlerode LC, Lucatorto EL, Wasserman TL, et al
    Frailty as Tested by Gait Speed Is a Risk Factor for Liver Transplant Respiratory Complications.
    Am J Gastroenterol. 2020 Mar 31. doi: 10.14309/ajg.0000000000000609.
    PubMed     Abstract available


  151. BAJAJ JS, Lauridsen M, Tapper EB, Duarte-Rojo A, et al
    Important Unresolved Questions in the Management of Hepatic Encephalopathy: An ISHEN Consensus.
    Am J Gastroenterol. 2020 Mar 30. doi: 10.14309/ajg.0000000000000603.
    PubMed     Abstract available


  152. KAPILA N, Dorsey YC, Shah J, King L, et al
    Transjugular Intrahepatic Portosystemic Shunt for a Challenging Pregnancy.
    Am J Gastroenterol. 2020 Mar 26. doi: 10.14309/ajg.0000000000000602.
    PubMed    


  153. LEE JK, Merchant SA, Schneider JL, Jensen CD, et al
    Proton Pump Inhibitor Use and Risk of Gastric, Colorectal, Liver, and Pancreatic Cancers in a Community-Based Population.
    Am J Gastroenterol. 2020 Mar 20. doi: 10.14309/ajg.0000000000000591.
    PubMed     Abstract available


    February 2020
  154. DAI C, Jiang M
    Women With Nonalcoholic Fatty Liver Disease Lose Protection Against Cardiovascular Disease?
    Am J Gastroenterol. 2020;115:303-304.
    PubMed    


  155. MILLER ED, Abu-Sbeih H, Styskel B, Nogueras Gonzalez GM, et al
    Clinical Characteristics and Adverse Impact of Hepatotoxicity due to Immune Checkpoint Inhibitors.
    Am J Gastroenterol. 2020;115:251-261.
    PubMed     Abstract available


    January 2020
  156. GORDON SC, Wu KH, Lindor K, Bowlus CL, et al
    Ursodeoxycholic Acid Treatment Preferentially Improves Overall Survival Among African Americans With Primary Biliary Cholangitis.
    Am J Gastroenterol. 2020 Jan 27. doi: 10.14309/ajg.0000000000000512.
    PubMed     Abstract available


  157. KLOMPENHOUWER AJ, Alblas M, van Rosmalen BV, Haring MPD, et al
    Response to Chen et al.
    Am J Gastroenterol. 2020;115:147-148.
    PubMed    


  158. MOON AM, Yang JY, Barritt AS 4th, Bataller R, et al
    Rising Mortality From Alcohol-Associated Liver Disease in the United States in the 21st Century.
    Am J Gastroenterol. 2020;115:79-87.
    PubMed     Abstract available


  159. SINGAL AK, Arora S, Wong RJ, Satapathy SK, et al
    Increasing Burden of Acute-On-Chronic Liver Failure Among Alcohol-Associated Liver Disease in the Young Population in the United States.
    Am J Gastroenterol. 2020;115:88-95.
    PubMed     Abstract available


  160. DANG K, Hirode G, Singal AK, Sundaram V, et al
    Alcoholic Liver Disease Epidemiology in the United States: A Retrospective Analysis of 3 US Databases.
    Am J Gastroenterol. 2020;115:96-104.
    PubMed     Abstract available


    November 2019
  161. CAZZAGON N, Lemoinne S, El Mouhadi S, Trivedi PJ, et al
    The Complementary Value of Magnetic Resonance Imaging and Vibration-Controlled Transient Elastography for Risk Stratification in Primary Sclerosing Cholangitis.
    Am J Gastroenterol. 2019 Nov 14. doi: 10.14309/ajg.0000000000000461.
    PubMed     Abstract available


  162. ALLEN AM, Therneau TM, Mara KC, Larson JJ, et al
    Women With Nonalcoholic Fatty Liver Disease Lose Protection Against Cardiovascular Disease: A Longitudinal Cohort Study.
    Am J Gastroenterol. 2019;114:1764-1771.
    PubMed     Abstract available


  163. HARRIS R, Card TR, Delahooke T, Aithal GP, et al
    Obesity Is the Most Common Risk Factor for Chronic Liver Disease: Results From a Risk Stratification Pathway Using Transient Elastography.
    Am J Gastroenterol. 2019;114:1744-1752.
    PubMed     Abstract available


    June 2019
  164. YOKODA RT, Carey EJ
    Primary Biliary Cholangitis and Primary Sclerosing Cholangitis.
    Am J Gastroenterol. 2019 Jun 4. doi: 10.14309/ajg.0000000000000268.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Liver Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: